Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.

Por Sanglard, D, Kuchler, K, Ischer, F, Pagani, J L, Monod, M, Bille, J
Publicado em 1995

Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users.

Por Boerlin, P, Boerlin-Petzold, F, Durussel, C, Addo, M, Pagani, J L, Chave, J P, Bille, J
Publicado em 1995

Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.

Por Boerlin, P, Boerlin-Petzold, F, Goudet, J, Durussel, C, Pagani, J L, Chave, J P, Bille, J
Publicado em 1996

Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care Unit

Por Fournier, A., Eggimann, P., Pantet, O., Pagani, J. L., Dupuis-Lozeron, E., Pannatier, A., Sadeghipour, F., Voirol, P., Que, Y.-A.
Publicado no Antimicrob Agents Chemother (2018)

Reply to Sorooshian and Snow, “Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?”

Por Fournier, A., Eggimann, P., Pantet, O., Pagani, J. L., Dupuis-Lozeron, E., Pannatier, A., Sadeghipour, F., Voirol, P., Que, Y.-A.
Publicado no Antimicrob Agents Chemother (2018)

Antibiotics’ consumption to early detect epidemics of P. aeruginosa in a burn center: a paradigm shift in the epidemiological surveillance of nosocomial infections

Por Fournier, A, Eggimann, P, Pantet, O, Krähenbühl, M, Bonnemain, C-L, Fournier, C, Pagani, J-L, Revelly, J-P, Dupuis-Lozeron, E, Sadeghipour, F, Pannatier, A, Voirol, P, Que, Y-A
Publicado no Antimicrob Resist Infect Control (2015)